查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496918

藥品契約製造市場：趨勢、機會與競爭分析 [2024-2030]

Pharmaceutical Contract Manufacturing Market: Trends, Opportunities and Competitive Analysis [2024-2030]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

藥品契約製造市場的趨勢與預測

預計到 2030 年，全球藥品契約製造市場將達到 2,984 億美元，2024 年至 2030 年複合年成長率為 7.9%。該市場的主要驅動力是對學名藥和專科藥物的需求不斷成長、藥品研發活動投資的增加以及尋求「一站式」效益的 CMO（契約製造組織）的成長趨勢。全球醫藥契約製造市場的未來前景廣闊，大型製藥公司、小型製藥公司和學名藥市場都有機會。

藥品契約製造市場洞察

  • Lucintel 預計，由於生產疫苗和生物相似藥的需求不斷成長，生技藥品製造在預測期內仍將是最大的細分市場。
  • 市場上大型藥局外包藥品生產以盡量減少價格壓力和管道問題的趨勢日益明顯，隨著暢銷藥物專利到期，對成本最佳化的需求也不斷增加。
  • 由於人口老化帶來的需求增加、外包活動的增加以及該地區主要企業製造能力的擴大，預計亞太地區仍將是最大的地區。

常問問題

Q1.市場規模為：

答：到2030年，全球藥品契約製造市場預計將達到2,984億美元。

Q2.市場成長預測是多少：

答：2024年至2030年，全球藥品契約製造市場預期複合年成長率為7.9%。

Q3.影響市場成長的主要促進因素是：

答：這個市場的主要驅動力是學名藥需求的成長、藥品研發活動投資的增加以及CMO（契約製造組織）尋求「一站式」效益的趨勢。

Q4.市場的主要細分市場是：

答：醫藥契約製造市場前景廣闊，大藥廠、小藥廠、學名藥市場都有機會。

Q5. 主要的藥品契約製造公司有哪些？

答：主要藥品契約製造企業如下：

  • Thermo Fisher Scientific
  • Catalent
  • Lonza
  • Almac Group
  • Recipharm
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • AbbVie

Q6. 未來哪個醫藥契約製造領域將是最大的？

答：Lucintel 預計，由於生產疫苗和生物相似藥的需求不斷成長，生技藥品製造在預測期內仍將是最大的細分市場。

Q7.未來五年預計哪些地區的市場成長最大？

答：由於人口老化帶來的需求增加、外包活動的增加以及該地區主要企業製造能力的擴大，預計亞太地區仍將是最大的地區。

Q8. 可以客製化報告嗎？

答：是的，Lucintel 提供 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球藥品契約製造市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球藥品契約製造市場趨勢（2018-2023）與預測（2024-2030）
  • 按服務分類的全球藥品契約製造市場
    • 製造業
      • API
      • FDF（注射劑、錠劑、膠囊、口服液）
    • 醫藥開發
    • 生技藥品製造
  • 按最終用途行業分類的全球藥品契約製造市場
    • 大型製藥公司
    • 中小醫藥
    • 學名藥
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 按地區分類的藥品契約製造市場
  • 北美藥品契約製造市場
  • 歐洲藥品契約製造市場
  • 亞太地區藥品契約製造市場
  • 其他地區藥品契約製造市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球藥品契約製造市場的成長機會（按服務分類）
    • 最終用途產業全球藥品契約製造市場的成長機會
    • 按地區分類的全球藥品契約製造市場成長機會
  • 全球藥品契約製造市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球藥品契約製造市場的產能
    • 全球藥品契約製造市場的合併、收購與合資企業
    • 認證和許可

第7章主要企業概況

  • Thermo Fisher Scientific
  • Catalent
  • Lonza
  • Almac Group
  • Recipharm
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • AbbVie
簡介目錄

Pharmaceutical Contract Manufacturing Market Trends and Forecast

The future of the global pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets. The global pharmaceutical contract manufacturing market is expected to reach an estimated $298.4 billion by 2030 with a CAGR of 7.9% from 2024 to 2030. The major drivers for this market are growing demand for generic and specialty medicines, increasing investments in pharmaceutical R&D activities, and rising trend for CMOs (contract manufacturing organization) for "one-stop-shop" benefit.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Pharmaceutical Contract Manufacturing Market by Segment

The study includes a forecast for the global pharmaceutical contract manufacturing market by services, end use industry, and region, as follows:

Pharmaceutical Contract Manufacturing Market by Services [Value ($B) Shipment Analysis from 2018 to 2030]:

  • Manufacturing
    • API
    • FDF (Parenteral, Injectable, Tablet, Capsule, and Oral Liquid)
  • Drug Development
  • Biologics Manufacturing

Pharmaceutical Contract Manufacturing Market by End Use Industry [Value ($B) Shipment Analysis from 2018 to 2030]:

  • Big Pharmaceutical
  • Small & Medium-Sized Pharmaceutical
  • Generic Pharmaceutical
  • Others

Pharmaceutical Contract Manufacturing Market by Region [Value ($B) Shipment Analysis from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pharmaceutical Contract Manufacturing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pharmaceutical contract manufacturing companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pharmaceutical contract manufacturing companies profiled in this report include.

  • Thermo Fisher Scientific
  • Catalent
  • Lonza
  • Almac Group
  • Recipharm
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • AbbVie

Pharmaceutical Contract Manufacturing Market Insights

  • Lucintel forecasts that biologics manufacturing will remain the largest segment over the forecast period due to increasing need for producing vaccines and biosimilars.
  • Within this market, big pharmaceutical segment is expected to remain the largest segment due to growing trend among large pharmacies to contract out pharmaceutical production in order to minimize the pricing pressure and pipeline issues in their operations along with increasing demand for optimization of execution costs as bestselling medication patents expires.
  • APAC is expected to remain the largest region due to increasing demand from geriatric population, growing outsourcing activities and expansion of manufacturing capabilities of the local key players in the region.

Features of the Pharmaceutical Contract Manufacturing Market

  • Market Size Estimates: Pharmaceutical contract manufacturing market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
  • Segmentation Analysis: Pharmaceutical contract manufacturing market size by various segments, such as by services, end use industry, and region
  • Regional Analysis: Pharmaceutical contract manufacturing market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by services, end use industry, and regions for the pharmaceutical contract manufacturing market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the pharmaceutical contract manufacturing market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the pharmaceutical contract manufacturing market size?

Answer: The global pharmaceutical contract manufacturing market is expected to reach an estimated $298.4 billion by 2030.

Q2. What is the growth forecast for pharmaceutical contract manufacturing market?

Answer: The global pharmaceutical contract manufacturing market is expected to grow with a CAGR of 7.9% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pharmaceutical contract manufacturing market?

Answer: The major drivers for this market are growing demand for generic and specialty medicines, increasing investments in pharmaceutical R&D activities, and rising trend for CMOs (contract manufacturing organization) for "one-stop-shop" benefit.

Q4. What are the major segments for pharmaceutical contract manufacturing market?

Answer: The future of the pharmaceutical contract manufacturing market looks promising with opportunities in the big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical markets.

Q5. Who are the key pharmaceutical contract manufacturing companies?

Answer: Some of the key pharmaceutical contract manufacturing companies are as follows:

  • Thermo Fisher Scientific
  • Catalent
  • Lonza
  • Almac Group
  • Recipharm
  • Patheon
  • Grifols International
  • Dalton Pharma Services
  • AbbVie

Q6. Which pharmaceutical contract manufacturing segment will be the largest in future?

Answer:Lucintel forecasts that biologics manufacturing will remain the largest segment over the forecast period due to increasing need for producing vaccines and biosimilars.

Q7. In pharmaceutical contract manufacturing market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to remain the largest region due to increasing demand from geriatric population, growing outsourcing activities and expansion of manufacturing capabilities of the local key players in the region.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

  • Q.1. What are some of the most promising, high-growth opportunities for the pharmaceutical contract manufacturing market by services (manufacturing [API, FDF (parenteral, injectable, tablet, capsule, and oral liquid)], drug development, and biologics manufacturing), end use industry (big pharmaceutical, small & medium-sized pharmaceutical, and generic pharmaceutical), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity did occur in the last five years and how did they impact the industry?

Table of Contents

1. Executive Summary

2. Global Pharmaceutical Contract Manufacturing Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1: Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2: Global Pharmaceutical Contract Manufacturing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pharmaceutical Contract Manufacturing Market by Services
    • 3.3.1: Manufacturing
      • 3.3.1.1: API
      • 3.3.1.2: FDF (Parenteral, Injectable, Tablet, Capsule, and Oral Liquid)
    • 3.3.2: Drug Development
    • 3.3.3: Biologics Manufacturing
  • 3.4: Global Pharmaceutical Contract Manufacturing Market by End Use Industry
    • 3.4.1: Big Pharmaceutical
    • 3.4.2: Small & Medium-Sized Pharmaceutical
    • 3.4.3: Generic Pharmaceutical
    • 3.4.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Pharmaceutical Contract Manufacturing Market by Region
  • 4.2: North American Pharmaceutical Contract Manufacturing Market
    • 4.2.1: North American Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
    • 4.2.2: North American Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
  • 4.3: European Pharmaceutical Contract Manufacturing Market
    • 4.3.1: European Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
    • 4.3.2: European Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
  • 4.4: APAC Pharmaceutical Contract Manufacturing Market
    • 4.4.1: APAC Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
    • 4.4.2: APAC Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical
  • 4.5: ROW Pharmaceutical Contract Manufacturing Market
    • 4.5.1: ROW Pharmaceutical Contract Manufacturing Market by Services: Manufacturing, Drug Development, and Biologics Manufacturing
    • 4.5.2: ROW Pharmaceutical Contract Manufacturing Market by End Use Industry: Big Pharmaceutical, Small & Medium-Sized Pharmaceutical, and Generic Pharmaceutical

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by Services
    • 6.1.2: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by End Use Industry
    • 6.1.3: Growth Opportunities for the Global Pharmaceutical Contract Manufacturing Market by Region
  • 6.2: Emerging Trends in the Global Pharmaceutical Contract Manufacturing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pharmaceutical Contract Manufacturing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pharmaceutical Contract Manufacturing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: Catalent
  • 7.3: Lonza
  • 7.4: Almac Group
  • 7.5: Recipharm
  • 7.6: Patheon
  • 7.7: Grifols International
  • 7.8: Dalton Pharma Services
  • 7.9: AbbVie